Xu X[au] - Search Results

Year	Number of Results
1963	1
1979	4
1980	3
1981	9
1982	9
1983	12
1984	24
1985	17
1986	15
1987	39
1988	38
1989	32
1990	44
1991	55
1992	72
1993	77
1994	130
1995	127
1996	151
1997	149
1998	141
1999	203
2000	219
2001	292
2002	358
2003	380
2004	487
2005	604
2006	639
2007	751
2008	975
2009	1107
2010	1295
2011	1516
2012	1731
2013	2138
2014	2503
2015	2816
2016	2901
2017	3183
2018	3701
2019	4149
2020	5014
2021	5679
2022	3252
2023	2

1

Stromal changes in the aged lung induce an emergence from melanoma dormancy.

Fane ME, Chhabra Y, Alicea GM, Maranto DA, Douglass SM, Webster MR, Rebecca VW, Marino GE, Almeida F, Ecker BL, Zabransky DJ, Hüser L, Beer T, Tang HY, Kossenkov A, Herlyn M, Speicher DW, Xu W, Xu X, Jaffee EM, Aguirre-Ghiso JA, Weeraratna AT. Fane ME, et al. Among authors: xu x. Nature. 2022 Jun;606(7913):396-405. doi: 10.1038/s41586-022-04774-2. Epub 2022 Jun 1. Nature. 2022. PMID: 35650435

2

Retraction Note: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.

Xu X, Zhang X, Zhang Y, Yang L, Liu Y, Huang S, Lu L, Kong L, Li Z, Guo Q, Zhao L. Xu X, et al. Sci Rep. 2022 May 30;12(1):9007. doi: 10.1038/s41598-022-13462-0. Sci Rep. 2022. PMID: 35637378 Free PMC article. No abstract available.

3

Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.

Liu X, Qin J, Gao T, Li C, He B, Pan B, Xu X, Chen X, Zeng K, Xu M, Zhu C, Pan Y, Sun H, Sun L, Xu T, Wang S. Liu X, et al. Among authors: xu x. Mol Ther Nucleic Acids. 2022 May 6;28:571. doi: 10.1016/j.omtn.2022.04.027. eCollection 2022 Jun 14. Mol Ther Nucleic Acids. 2022. PMID: 35592497 Free PMC article.

4

Retraction notice to " Tetramethylpyrazine alleviates lipopolysaccharide-induced damage in ATDC5 cells via down-regulating MyD88" [Experimental and Molecular Pathology 111 (2019) 104317].

Li Q, Xing W, Xu X, Wang S, He Y, Wang Y, Sun H. Li Q, et al. Among authors: xu x. Exp Mol Pathol. 2022 Jun;126:104779. doi: 10.1016/j.yexmp.2022.104779. Epub 2022 May 23. Exp Mol Pathol. 2022. PMID: 35618516 No abstract available.

5

Mitigating COVID-19 Transmission in Schools With Digital Contact Tracing.

Sun HC, Liu XF, Du ZW, Xu XK, Wu Y. Sun HC, et al. Among authors: xu xk. IEEE Trans Comput Soc Syst. 2021 Apr 28;8(6):1302-1310. doi: 10.1109/TCSS.2021.3073109. eCollection 2021 Dec. IEEE Trans Comput Soc Syst. 2021. PMID: 35582036 Free PMC article.

6

Cyclodextrin-Confined Supramolecular Lanthanide Photoswitch.

Yu HJ, Wang H, Shen FF, Li FQ, Zhang YM, Xu X, Liu Y. Yu HJ, et al. Among authors: xu x. Small. 2022 Jun;18(24):e2201737. doi: 10.1002/smll.202201737. Epub 2022 May 18. Small. 2022. PMID: 35585680

7

[Naringenin promotes osteogenic differentiation of BMSCs via SDF-1α/CXCR4 signaling axis].

Bai SL, Wang YP, Jin K, Luo XL, Xu XM. Bai SL, et al. Among authors: xu xm. Shanghai Kou Qiang Yi Xue. 2021 Dec;30(6):579-584. Shanghai Kou Qiang Yi Xue. 2021. PMID: 35587010 Chinese.

8

Deep learning-based detection and segmentation of diffusion abnormalities in acute ischemic stroke.

Liu CF, Hsu J, Xu X, Ramachandran S, Wang V, Miller MI, Hillis AE, Faria AV; STIR and VISTA Imaging investigators. Liu CF, et al. Among authors: xu x. Commun Med (Lond). 2021 Dec 16;1:61. doi: 10.1038/s43856-021-00062-8. eCollection 2021. Commun Med (Lond). 2021. PMID: 35602200 Free PMC article.

9

A community approach to the cancer-variant-interpretation bottleneck.

Krysiak K, Danos AM, Kiwala S, McMichael JF, Coffman AC, Barnell EK, Sheta L, Saliba J, Grisdale CJ, Kujan L, Pema S, Lever J, Spies NC, Chiorean A, Rieke DT, Clark KA, Jani P, Takahashi H, Horak P, Ritter DI, Zhou X, Ainscough BJ, Delong S, Lamping M, Marr AR, Li BV, Lin WH, Terraf P, Salama Y, Campbell KM, Farncombe KM, Ji J, Zhao X, Xu X, Kanagal-Shamanna R, Cotto KC, Skidmore ZL, Walker JR, Zhang J, Milosavljevic A, Patel RY, Giles RH, Kim RH, Schriml LM, Mardis ER, Jones SJM, Raca G, Rao S, Madhavan S, Wagner AH, Griffith OL, Griffith M. Krysiak K, et al. Among authors: xu x. Nat Cancer. 2022 May;3(5):522-525. doi: 10.1038/s43018-022-00379-w. Nat Cancer. 2022. PMID: 35624339 No abstract available.

10

Toripalimab in advanced biliary tract cancer.

Li W, Wang Y, Yu Y, Li Q, Wang Y, Zhang C, Xu X, Guo X, Dong Y, Cui Y, Hao Q, Huang L, Liu H, Liu T. Li W, et al. Among authors: xu x. Innovation (Camb). 2022 May 10;3(4):100255. doi: 10.1016/j.xinn.2022.100255. eCollection 2022 Jul 12. Innovation (Camb). 2022. PMID: 35615603 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results